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ABCD1 and its homolog ABCD2 are peroxisomal ATP-bind-
ing cassette (ABC) half-transporters of fatty acyl-CoAs with
both distinct and overlapping substrate specificities. Although
it is established that ABC half-transporters have at least to
dimerize to generate a functional unit, functional equivalents of
tetramers (i.e. dimers of full-length transporters) have also been
reported. However, oligomerization of peroxisomal ABCD
transporters is incompletely understood but is of potential sig-
nificance because more complex oligomerization might lead to
differences in substrate specificity. In this work, we have char-
acterized the quaternary structure of the ABCD1 and ABCD2
proteins in the peroxisomalmembrane. Using various biochem-
ical approaches, we clearly demonstrate that both transporters
exist as both homo- and heterotetramers, with a predominance
of homotetramers. In addition to tetramers, some larger molec-
ular ABCD assemblies were also found but represented only a
minor fraction. By using quantitative co-immunoprecipitation
assays coupled with tandem mass spectrometry, we identified
potential binding partners of ABCD2 involved in polyunsatu-
rated fatty-acid metabolism. Interestingly, we identified cal-
cium ATPases as ABCD2-binding partners, suggesting a role of
ABCD2 in calcium signaling. In conclusion, we have shownhere
that ABCD1 and its homolog ABCD2 exist mainly as homote-
tramers in the peroxisomal membrane.
The ABCD1 transporter belongs to the D subfamily of
the ATP-binding cassette (ABC)2 transporter family and is
encoded by the ABCD1 gene (1). A large number of mutations
in ABCD1 are responsible for the most common peroxisomal
disorder, which is called X-linked adrenoleukodystrophy
(X-ALD) (2). Expressed at the peroxisomal membrane, ABCD1
mediates the import of saturated and monounsaturated very
long-chain fatty acids (VLCFA) as CoA esters into the peroxi-
some for their further degradation by -oxidation (3–5). A
defect in ABCD1 results in increased levels of VLCFA in tissues
and plasma (4).
Two homologs of ABCD1 that belong to the sameD subfam-
ily are expressed in the peroxisome: ABCD2 (6) and ABCD3,
also called PMP70 (7). ABCD2, the closest homolog, shares the
same substrate preferencewithABCD1 for saturated fatty acids
(FA) and monounsaturated FA (MUFA) but has a distinct sub-
strate preference for shorter VLCFA and polyunsaturated FA
(PUFA) (5, 8, 9). ABCD3 has the broadest substrate specificity
because it is involved in the transport of saturated FA, unsatu-
rated FA, branched-chain FA, dicarboxylic FA, and C27 bile
acid intermediates (10, 11).
The partial overlap in substrate specificity between ABCD1
and its homologs explains their ability, upon overexpression, to
compensate for ABCD1 defect (12–14). However, the basal
expression levels of ABCD2 and ABCD3 are not sufficient to
allow the compensation mechanisms to be efficient enough in
X-ALD patients. Thismay be explained by the fact that ABCD2
expression mirrors ABCD1 distribution in many cell types in
different tissues (15) and by the fact that ABCD3, although
ubiquitously expressed (16, 17), has mainly a distinct substrate
specificity (10, 11) and mediates the transport of ABCD1 sub-
strates with less efficiency (3).
Peroxisomal ABCD transporters are half-transporters con-
taining one nucleotide-binding domain (NBD) and one trans-
membrane domain as opposed to ABC full-length transporters
that contain two copies of each domain. It is therefore com-
monly accepted that half-transporters have to dimerize to gen-
erate a minimal functional unit. The expression pattern of per-
oxisomal ABC transporters allows, in principle, the formation
of all combinations of heterodimers. Indeed, ABCD3 is ubiqui-
tously expressed, and although ABCD2 expression mirrors
ABCD1 distribution in many cell types in different tissues,
ABCD2 expression is highly inducible (18). Thus, upon stimu-
lation, both proteins can be expressed in the same cell. Actually,
the presence of both peroxisomal ABCD heterodimers and
homodimers has been evidenced mainly by FRET and co-im-
munoprecipitation (co-IP) assays (8, 19–23). In addition,
because chimeric proteinsmimicking homo- and heterodimers
of ABCD1 and ABCD2 are functionally active (24), one can
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speculate that alternative dimerization of peroxisomal ABCD
transporters could lead to different substrate specificity.
It is noteworthy that the level of molecular complexity for
peroxisomal ABCD half-transporters might be underesti-
mated. Indeed, other ABC half-transporters, such as ABCG2,
exhibit a tetrameric organization consisting in four core
domains (25). Moreover, dimers of full-length transporters
(also yielding a four-core domain organization) were observed
for ABCA1 (26), ABCA3 (27), ABCC1 (28), and ABCC7 (29).
Therefore, it is tempting to speculate that the interactions
described within the peroxisomal ABCD subfamily occur
within a higher oligomeric structure, such as a tetramer. If the
substrate specificity is determined by the oligomeric status of
ABCD1 and its homologs, it is essential to analyze their quater-
nary structure.
In this work, our objective was to study the quaternary
structure of ABCD1 and ABCD2 proteins in the peroxisomal
membrane by combining different biochemical approaches,
including velocity sucrose gradient centrifugation, co-im-
munoprecipitation assays, and native PAGE.We evidenced the
presence of tetrameric forms whose ABCD1/ABCD2 composi-
tion was explored and whose stability was evaluated during the
catalytic cycle of the transporters. In addition, the composition
of even higher molecular assemblies containing ABCD2 was
deciphered by quantitative co-IP assays coupled to tandem
mass spectrometry.
Results
High-molecular weight assembly of ABCD1 and ABCD2
We characterized the oligomeric state of ABCD1 and
ABCD2 proteins by analyzing on a sucrose gradient the corre-
sponding cell lysate fractions obtained by using either a dena-
turing detergent, such as SDS; mild detergents, such as Triton
X-100,-dodecylmaltopyranoside (-DDM), or-DDM; and a
stabilizing detergent, C4C8 (30). Cell lysates were obtained
from a specific H4IIEC3 hepatoma cell model that does not
express ABCD2 at the basal level but expresses a functional
ABCD2-EGFP fusion protein, depending on the dose of doxy-
cycline added in the culturemedium (clone 28.38) (8, 31). Com-
pared with ABCD3, the ABCD1 gene expression level is rela-
tively low (31), but the ABCD1 protein expression level is
sufficient to allow VLCFA -oxidation measurements (8). At
floating equilibrium, 22 fractions were collected from a 5–30%
(w/v) sucrose gradient, checked for linearity (Fig. 1A), and cal-
ibrated with native soluble markers (Fig. 1B) and with a mem-
brane protein marker (denatured ABCD2-ABCD2-EGFP; Fig.
1C) performed to ensure a more accurate interpretation of the
results. Indeed, it should be noted that the sedimentation prop-
erties of membrane proteins depend on the amount of mem-
brane lipids and detergent bound (size of the micelle). Thus,
ABCD1- and ABCD2-particle floatation data were analyzed by
considering the apparent size of the complexes based on the
position of the chimericABCD2-ABCD2-EGFPproteinmarker
and by considering the shift in peak positions obtained depend-
ing on the detergents.
The 22 collected sucrose fractions were analyzed byWestern
blotting for the presence of ABCD1 (82 kDa) and ABCD2-
EGFP (111 kDa). The sedimentation of proteins solubilized
with SDS was observed in fractions 6 and 7 for ABCD1 and
fractions 7 and 8 for ABCD2-EGFP (Fig. 2). The molecular
weights corresponding to these fractions are in agreement with
a monomeric state for both ABCD1 and ABCD2-EGFP. This
result was expected, considering the denaturing nature of the
detergent used.
Upon solubilization with the mild detergent -DDM,
ABCD1 and ABCD2-EGFP floated as high-molecular mass
complexes with a peak centered at fractions 11–14 of 215–415
kDa and at fractions 12–15 of 270–515 kDa, respectively (Fig.
2). These complexes could correspond to tetrameric associa-
tions, considering the monomeric molecular mass of ABCD1
(82 kDa) and ABCD2-EGFP (111 kDa) and the -DDMmicelle
size (38.3 kDa) (32) and considering the important shift
obtained from fractions 9 and 10 of the chimeric dimer
ABCD2-ABCD2-EGFP (Fig. 1C) to the above denser fractions.
The use of detergents with intermediate strength, such as
C4C8, Triton X-100, or -DDM (Fig. 2), tended to destabilize
the high-molecular weight complexes to likely dimeric forms.
Indeed, upon fractionation in the presence of these detergents,
ABCD1 and ABCD2-EGFP signals were found in fractions 9
Figure 1. Calibration of velocity sucrose gradients with soluble andmembrane proteinmarkers. A, 5–30% (w/v) sucrose gradient linearity was checked
bymonitoring of sucrose concentration using a refractometer. Fractions 1–22 correspond to fractions from the top to thebottomof the gradient. B, calibration
curvewas drawn from the flotation of native soluble proteinmarkers (t, thyroglobulin (669 kDa); cat, catalase (232 kDa); b,-amylase (200 kDa); c, conalbumin
(75 kDa); o, ovalbumin (44 kDa)) in parallel and equivalent sucrose gradients. C, ABCD2-ABCD2-EGFP (194 kDa) solubilized with 1% SDS, used as a membrane
protein size marker, floated in fractions 9 and 10 (indicated by a gray bar) as monitored by densitometry analysis of immunoblotting performed with an
anti-GFP antibody for all collected fractions.
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and 10, which corresponds to the position of the ABCD2 chi-
meric dimers (Fig. 1C).
Altogether, our fractionation experiments show that high-
molecular weight assemblies of ABCD1 and ABCD2 are pres-
ent, and their proportions were found to increase as the
strength of the detergent used decreased. Upon solubilization
with the milder detergent (-DDM), the majority of high-
molecular weight assemblies could correspond to tetrameric
associations.
Interaction between ABCD1 and ABCD2within supradimeric
assemblies
We took advantage of the C4C8 detergent that solubilized
ABCD1 andABCD2-EGFP as amonomer/dimermix to further
characterize the dimer content. To determine whether or not
heterodimers exist, we performed a cell lysis with C4C8 and
immunoprecipitated ABCD2-EGFP with an anti-GFP anti-
body. PVDF membranes containing the immune complexes
were probed with the anti-ABCD1 antibody. IP assays per-
formedwith non-inducedABCD2-EGFP lysate (“dox” condi-
tion) were used as a control. The anti-GFP antibody immuno-
precipitated 40% of ABCD2-EGFP (Fig. 3, A and C), but no
specific co-immunoprecipitation of ABCD1 was detected
(when comparingdox anddox lanes in Fig. 3A), suggesting
the presence of only ABCD2-EGFP within the dimer. The
absence of interaction betweenABCD1 andABCD2-EGFPpre-
viously solubilized with C4C8 was further confirmed by the
anti-ABCD1 IP, which failed to reveal ABCD2-EGFP in the
co-IP fraction (data not shown).
However, ABCD1/ABCD2-EGFP interaction was evidenced
when co-IP assays were performed on cell lysates obtainedwith
Triton X-100, a milder detergent compared with C4C8 (Fig.
3B). Nevertheless, the percentage of co-immunoprecipitated
ABCD2-EGFP with ABCD1was relatively low; ABCD1 (88.8
11.2% of the pool) co-immunoprecipitated only 6.4  1.9% of
the ABCD2-EGFP pool (Fig. 3D).Moreover, cross-co-IP exper-
iments showed that a small fraction of ABCD1 was co-immu-
noprecipitated (2.9 0.1%) with ABCD2-EGFP (30.7 12.5%
of the pool).
We performed quantitative cross co-IPs in BV-2 cells, a
microglial cell line described to naturally express ABCD1 and
ABCD2 (33). We found on one hand that the ABCD1 expres-
sion level is slightly lower in BV-2 cells than in hepatoma cells
(induced clone 28.38) and, on the other hand, the expression
level of the endogenous ABCD2 is comparable with the forced
Figure2. Velocity sedimentationofABCD1andABCD2-EGFP-containing
particles on sucrose gradients is dependent on the detergent used.
Denatured monomeric ABCD1 and ABCD2-EGFP (from SDS lysis of induced
clone 28.38) sedimented in fractions 6 and 7 and in fractions 7 and 8, respec-
tively. In thepresenceof themild detergent-DDM,ABCD1andABCD2-EGFP
floated as high-molecular weight complexes in fractions 11–14 of 215–415
kDa and in fractions 12–15 of 270–515 kDa, respectively. Detergents with
intermediate strength (C4C8, Triton X-100, or -DDM) destabilized these
high-molecular weight complexes, considering the shift obtained to lighter
fractions. The densitometric analysis of ABCD1 and ABCD2-EGFP signals
detected in the gradient fractions by immunoblotting (anti-ABCD1 and anti-
GFP antibodies) is given as relative signal intensity and is representative of at
least two independent experiments. The positions of the soluble and mem-
brane (position of 194-kDa ABCD2-ABCD2-EGFP indicated by a gray bar) pro-
tein markers are indicated.
Figure 3. ABCD1/ABCD2 interaction by co-immunoprecipitation assays
depends on the detergent used. Whole-cell lysates of clone 28.38 (/
dox) in the presence of 1% C4C8 (A and C) or 1% Triton X-100 (B and D) were
used for anti-GFP and anti-ABCD1 IP assays. Input (one-eighth of the total
amountwas loaded) and eluted proteins, including immunoprecipitated and
co-immunoprecipitated proteins, were analyzed by SDS-PAGE followed by
immunoblottingwith anti-ABCD1andanti-GFP antibodies.A andB, immuno-
blots shown are representative of three independent experiments. C and D,
percentage of immunoprecipitated and co-immunoprecipitated ABCD1 and
ABCD2-EGFP proteins (of the input referred to as 100%). When ABCD1 and
ABCD2-EGFP were solubilized in the presence of C4C8, no specific co-immu-
noprecipitation was detected, although a significant co-immunoprecipita-
tion was obtained when solubilized by Triton X-100. Data are mean  S.D.
(error bars) (n 3).
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expression of ABCD2-EGFP in the induced clone 28.38 (Fig.
4A). The analysis of repeated co-IP experiments should be
approached with caution because a very low amount of immu-
noprecipitated ABCD1 (10.45  2.8%) and ABCD2-EGFP
(8.57  1.5%) was obtained. Nevertheless, if we consider the
above 8–10% of the immunoprecipitated proteins, ABCD1/
ABCD2 interaction seems to be favored in microglial cells in
comparisonwith hepatoma cells (induced clone 28.38). Indeed,
the same overall percentage of co-IP proteins was obtained in
hepatoma cells (2.9–6.4%; Fig. 3D) and in BV-2 cells (2.3–6.1%;
Fig. 4B), although the percentage of immunoprecipitated pro-
teins was much higher in hepatoma cells (30–88%; Fig. 3D)
than in BV-2 cells (8–10%; Fig. 4B).
If the interaction between ABCD1 and ABCD2 or ABCD2-
EGFP in ABCD2-naturally expressing cells (microglial BV-2
cells) or in ABCD2-EGFP-expressing hepatoma cells was
clearly observed, it remained to evaluate whether the interac-
tion occurs within a dimer or within higher molecular assem-
blies. The absence of ABCD1/ABCD2 interaction when sol-
ubilized with C4C8 and the presence of ABCD1/ABCD2
interaction when solubilized with the milder detergent Triton
X-100 suggest that this interaction does not occur within a
dimer but rather within supradimeric assemblies.
Homo- and heterotetrameric forms of ABCD1 and ABCD2
The fractionation experiments previously showed that
ABCD1 and ABCD2-EGFP are present in high-molecu-
lar weight assemblies that could correspond to tetrameric
associations.
Chimeric proteins containing two ABCD1 or ABCD2
moieties were previously reported to be functional (24).
When co-expressing ABCD1 chimeric homodimers ABCD1-
ABCD1 and ABCD1-ABCD1-EGFP in COS-7 cells, co-IP
experiments showed that ABCD1-ABCD1 specifically inter-
acts with ABCD1-ABCD1-EGFP, directly confirming the
existence of ABCD1 homotetramers (Fig. 5A). The presence of
ABCD2 homotetramers was confirmed as well by co-IP exper-
iments in cells expressing ABCD2 chimeric homodimers
(ABCD2-ABCD2 plus ABCD2-ABCD2-EGFP) (Fig. 5B). Het-
erotetramers as a result of an assembly of the two different
homodimers ABCD1-ABCD1 and ABCD2-ABCD2-EGFP were
detected similarly (Fig. 5C).
We further explored the ABCD1 andABCD2 oligomeric sta-
tus by native PAGE. To that end, we used a protocol for mem-
brane proteins that we adapted by replacing glycine by histidine
in the cathode buffer for sample focusing to take into account
the basic character of ABCD1 and ABCD2 proteins (34). To
improve the migration of membrane proteins, we used the
Deriphat (disodium-N-lauryl--iminodipropionate; Ana-
trace)-PAGE system adapted from Peter and Thornber (35)
successfully used for an ABC full-length transporter (36). The
peroxisome-enriched fraction was prepared from the ABCD2-
EGFP-expressing hepatoma cells (induced clone 28.38), and
ABCD1 and ABCD2-EGFP were solubilized with the milder
detergent -DDM. Surprisingly, the extraction of ABCD1 and
ABCD2 proteins from peroxisomal membranes by -DDM
micelles was drastically increased when peroxisomes were
incubated with ATP before incubation with the detergent (Fig.
6A). ABCD1 and ABCD2-EGFP solubility increased from
13.7 10.3 to 65 9.6% and from 7.9 11.4 to 43.6 22.1%,
respectively (Fig. 6B). Native electrophoresis of solubilized
ABCD1 and ABCD2-EGFP proteins using the Deriphat-PAGE
system resulted in a prominent band with an apparent molec-
ular mass of350 kDa for ABCD1 (Fig. 6C) and480 kDa for
ABCD2-EGFP (Fig. 6D), whereas single proteins have a molec-
ular mass of 82 and 111 kDa, respectively. This suggests that
both proteinsmay assemble as a tetramer. Of note, ABCD1, but
not ABCD2-EGFP, was also systematically detected as a faint
band at 200 kDa consistent with dimeric assembly (Fig. 6C).
Superimposition of the densitometric tracing of the native-
PAGEelectrophoretic patterns clearly showed thatABCD1 and
ABCD2-EGFP were mainly present in distinct complexes, as
evidenced by a weak overlapping of ABCD1 and ABCD2-EGFP
bands (Fig. 6E).
Solubilized ABCD1 and ABCD2 from the peroxisome-en-
riched fraction of BV-2 cells preincubated or notwithATP (Fig.
7A) showed that both proteins are found in high-molecular
weight complexes as well on native PAGE (Fig. 7B). However,
both proteinswere detected in broader bandswith an estimated
apparent molecular mass in the range of 350–700 kDa for
ABCD1 (Fig. 7B, left) and in the range of 480–700 kDa for
ABCD2 (Fig. 7B, right), consistent with the presence of at least
tetrameric forms.
Altogether, ABCD1 and ABCD2 can form homotetramers
and heterotetramers, as demonstrated by co-IP assays of chi-
meric dimers. Moreover, native-PAGE experiments showed
that high-molecular weight assemblies for both transporters
are present in BV-2 cells and in induced clone 28.38 and
are likely to correspond to tetrameric associations, mainly
homotetramers.
Figure 4. ABCD1 interacts with ABCD2 in the BV-2 microglial cell line. A,
histograms showing the relative ABCD1 andABCD2protein expression levels
as determined by densitometric analysis of immunoblots with anti-ABCD1
(left) and anti-ABCD2 (right) antibodies after normalization with actin, in
mouse BV-2 cells and in rat hepatoma-induced clone 28.38. Whereas sim-
ilar ABCD2 levels are found, a 1.5-fold increase in ABCD1 expression was
found in BV-2 cells compared with the induced clone 28.38. Values are
mean S.D. (n 3). B, cross-co-IP experiments showed that ABCD1 inter-
acts with ABCD2 in BV-2 cells. Whole-cell Triton X-100 lysates of BV-2 cells
were used for anti-ABCD1 and anti-ABCD2 IP. Input and eluted proteins
were analyzed by SDS-PAGE, followed by immunoblotting with anti-
ABCD1 and anti-ABCD2 antibodies. Histograms show the mean percent-
age  S.D. (error bars) of immunoprecipitated and co-immunoprecipi-
tated proteins (out of the input referred as 100%) for three independent
experiments.
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ABCD1 and ABCD2 tetrameric assemblies remain unchanged
during the catalytic cycle of the transporters
We next analyzed whether activation or inactivation of the
ATP-driven fatty-acid transport assumed by ABCD1 and
ABCD2 could be associated with an altered ability to tetramer-
ize and could trap transient assembly.
Blocking ATP hydrolysis activity of ABCD1 and ABCD2 was
provided by the peroxisome-enriched fraction treatmentwith a
non-hydrolyzable competitor of ATP (AMP-PNP). Similarly to
ATP, preincubation of peroxisomes with AMP-PNP drastically
increased the extraction of ABCD1 andABCD2-EGFP proteins
from peroxisomal membranes by -DDM micelles (Fig. 8A),
indicating that nucleotide binding but not nucleotide hydroly-
sis is responsible for such an elevated extraction yield. Analysis
of these -DDM-soluble fractions on Deriphat-PAGE showed
that ABCD1 and ABCD2-EGFP high-molecular weight assem-
blies (i.e. tetramers) remained unchanged whatever the condi-
tions (Fig. 8B).
Stimulation of the ATP-driven fatty-acid transport was
obtained by incubation of isolated peroxisomes in the presence
of ATP, fatty acid (C26:0), and the cytosolic fraction, previously
reported to be needed for functional -oxidation in isolated
peroxisomes (3). The subsequent analysis revealed a compara-
ble ABCD1 and ABCD2-EGFP extraction efficiency in all
treated samples (Fig. 8C) and the same banding pattern on
Deriphat-PAGE (Fig. 8D).
Overall, by interfering with the ATP-driven fatty-acid
transport assumed by ABCD1 and ABCD2-EGFP, our data
indicate that ABCD1 and ABCD2-EGFP tetrameric assem-
blies remain unchanged during the catalytic cycle of both
transporters and hence that these transporters probably
form obligate tetramers.
Identification of potential ABCD2-binding partners
The asymmetric peaks seen on native-PAGE profiles with a
shoulder toward the high-molecular weight region both for
ABCD1 and ABCD2 (Figs. 6E and 7B) suggested that besides
tetrameric forms, higher molecular assemblies of ABCD1 and
ABCD2 are present (up to 720 kDa). We wondered whether
ABCD1 and ABCD2 form oligomeric structures (4 mono-
mers) or belong to a complex formed by a tetramer interacting
with other proteins.
To identify potential interacting partners specific for
ABCD2, we developed a co-IP/mass spectrometry (MS) strat-
egy. The -DDM soluble fraction of the peroxisome-enriched
fraction, prepared from the clone 28.38 expressing or not
expressing ABCD2-EGFP, was subjected to anti-GFP co-IP
assays. Quantitative liquid chromatography-electrospray ioni-
zation-tandem mass spectrometry was used to identify eluted
proteins from co-IP assays. Differential analysis between sam-
ples expressing or not expressing ABCD2-EGFP (dox/dox)
was performed to limit identification of false-positive interac-
tions. Hence, only proteins detected exclusively in the positive
samples were listed (Table 1). ABCD2 was successfully identi-
fied, with 26 unique peptides to ABCD2 and two shared pep-
tides between ABCD1 and ABCD2 leading to 51.7% ABCD2
sequence coverage. Interestingly, a total of 13 non-redundant
proteins were found to potentially interact with ABCD2-EGFP
(Table 1). Four of them are statistically relevant (-fold change
 2): the fatty-acid amide hydrolase 1 (FAAH1), the sarcoplas-
mic/endoplasmic reticulum calcium ATPase 2 (AT2A2), the
sodium/potassium-transporting ATPase subunit -1 (AT1B1),
and the serum paraoxonase/arylesterase 1 (PON1).
Discussion
For the first time, we demonstrate the presence of tetrameric
assemblies of the peroxisomal ABCD1 and ABCD2 transport-
ers in rodents, although the scientific community has previ-
ously reported a dimeric status for peroxisomal ABCDproteins
in yeast (37, 38), rodents, or humans (8, 19–23). Our data
clearly demonstrate that ABCD1 and ABCD2-EGFP are found
in high-molecular weight complexes, which could correspond
to tetramers, as assessed by velocity gradient centrifugation
when solubilized with the mild detergent -DDM. Tetrameric
assemblies were further evidenced by co-IP assays of functional
chimeric dimers expressed in transfected COS-7 cells. Opti-
Figure 5. ABCD1 and ABCD2 are present in homo- and heterotetramers.
Co-IP experiments were performed from single- and double-transfected
COS-7 cells with plasmids that encode for chimeric ABCD1dimers or chimeric
ABCD2 dimers either fused to EGFP or not. Single (negative control)- and
double-transfected cell lysates (400 g) were used for the anti-GFP IP exper-
iments. Input (50 g) and eluted proteins (IP and co-IP proteins) were ana-
lyzed by SDS-PAGE and immunoblotting with the antibodies indicated.
Immunoblots are representative of three independent experiments. A, using
an anti-GFP antibody, co-IP of ABCD1-ABCD1 (band at160 kDa; right) with
ABCD1-ABCD1-EGFP showed the presence of ABCD1 homotetramers. The
anti-GFP IP performed on ABCD1-ABCD1-transfected COS-7 cells, used as
negative control, revealed no band (left). B, using an anti-GFP antibody, co-IP
of ABCD2-ABCD2 (band at160 kDa; right) with ABCD2-ABCD2-EGFP dem-
onstrated the presence of ABCD2 homotetramers. No bandwas detected for
the negative IP control (left). C, using an anti-GFP antibody, co-immunopre-
cipitation of ABCD1-ABCD1 (band at 160 kDa; right) with ABCD2-ABCD2-
EGFP showed thepresence of heterotetramers. Nobandwas detected for the
negative IP control (left panels reused A).
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mized native-PAGE experiments confirmed that tetrameric
assemblies were predominant in ABCD2-EGFP forced expres-
sion cells (clone 28.38) and in ABCD1/ABCD2-naturally
expressing cells (BV-2) aswell. Theweak overlap ofABCD1 and
ABCD2 bands on native-PAGE profiles indicates that homote-
tramers are greatly favored over the heterotetramers. Previous
bioluminescence resonance energy transfer experiments have
led to the conclusion that homo-oligomerization of ABCD1 is
favored over hetero-oligomerization with ABCD3 (39). More-
over, ABCD1 homointeraction, interpreted as a dimer, was also
found to be either predominant in transfected cells (21) or
exclusive in the liver (22), an organwith lowABCD2 expression
level (2, 16). Hence, the predominance of homotetramers over
heterotetramers is consistent with previous data reporting pre-
ferred homointeraction over heterointeraction.
In an attempt to decipher the composition of the tetrameric
forms, we took advantage of the C4C8 detergent, which solubi-
lized ABCD1 and ABCD2-EGFP as a mix of monomer/dimer.
Figure 6. Presence of ABCD1 and ABCD2-EGFP in distinct high-molecular weight complexes in rat hepatoma cells by native PAGE. ABCD1 and
ABCD2-EGFP membrane extraction from induced clone 28.38 was performed by -DDM-containing solubilization buffer on peroxisome-enriched fraction
preincubated or notwith ATP.A, after centrifugation, the resulting soluble (supernatant (s)) and insoluble (pellet (p)) fractionswere analyzed by SDS-PAGE and
immunoblotting. Immunoblots are representative of three independent experiments. B, histograms representing the densitometric analysis of immunoblots
of solubilized ABCD1 and ABCD2-EGFP from the peroxisome-enriched fraction preincubated or not with ATP. A markedly increased solubility of ABCD1
(4.7-fold) and ABCD2-EGFP (5.5-fold) was obtainedwith ATP. Values aremean S.D. (error bars) (n 6). C andD, analysis of the soluble fraction (with/without
ATP conditions) bynative PAGE. The samePVDFmembranewasused for immunoblottingwith the anti-ABCD1antibody (C) andwith the anti-GFP antibody (D)
aftermembrane stripping, todetectABCD1andABCD2-EGFPproteins, respectively. The samenativemolecularmassmarker lane is indicated at the left. ABCD1
is detected as amajor band at350 kDa consistent with tetrameric assembly and as a faint band at200 kDa consistent with dimeric assembly. ABCD2-EGFP
is only detected as a major band at 480 kDa consistent with tetrameric assembly. E, superimposition of the densitometric tracing of the native-PAGE
electrophoretic patterns showed that ABCD1 and ABCD2 were mainly present in distinct complexes, as shown by a weak overlapping of ABCD1 and ABCD2-
EGFP bands. The native-PAGE immunoblotting images are representative of several experiments performed.
Figure 7. Native-PAGE profiles of ABCD1 and ABCD2 in the BV-2 microglial cell line. A, histograms representing the percentage of -DDM-solubilized
ABCD1 and ABCD2 proteins from the BV-2 cell peroxisome-enriched fraction, preincubated or not with ATP. Values are mean S.D. (error bars) (n 3). The
densitometric analyses were performed on immunoblots using the anti-ABCD1 and anti-ABCD2 antibodies. B, native-PAGE profiles of solubilized ABCD1 and
ABCD2, as described inA showed that both proteins are found in high-molecular weight complexes. The same PVDFmembranewas used for immunoblotting
with the anti-ABCD1 antibody (left) and with the anti-GFP antibody (right) after membrane stripping. In both panels, the same native molecular mass marker
lane is indicated at the left. ABCD1 is detected in a large bandwith an estimatedmolecularmass in the range of 350–700 kDa (left). ABCD2 is detected in a large
band as well, with an estimated molecular mass in the range of 480–700 kDa (right).
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This detergent belongs to the anionic calix[4]arene-based
detergent described to successfully extract several functional
ABChalf-transporters as dimers (30). Interestingly, the absence
of interaction of ABCD1 with ABCD2-EGFP by co-IP experi-
ments when solubilized with C4C8 suggests that homointerac-
tion is greatly favored or pushed to the extreme that only
homointeraction would exist within a dimer. This result calls
into question the relevance of the chimeric heterodimers that
we previously constructed and studied (24). Despite the fact
that the chimeric heterodimers were functionally active, we
were intrigued by theirmuch lower expression levels compared
with chimeric homodimers. The results observed for chimeric
heterodimers after temperature rescue experiments suggest
that the low expression level is due to folding defects. Thus, the
absence of interaction of ABCD1 with ABCD2 within a dimer,
as evidenced by co-IP, suggests that ABCD1/ABCD2 het-
Figure 8. Unchanged ABCD1- and ABCD2-EGFP molecular assemblies during the catalytic cycle of the transporters. A, histograms representing the
percentageof-DDM-solubilizedABCD1 andABCD2-EGFPproteins from the induced clone 28.38 peroxisome-enriched fractionpreincubatedor notwithATP
or AMP-PNP. The densitometric analyses were performed on immunoblots using the anti-ABCD1 and anti-GFP antibodies. Values aremean S.D. (error bars)
(n  3). B, native-PAGE profiles of solubilized ABCD1 and ABCD2-EGFP, as described in A. The same PVDF membrane was used for immunoblotting with
anti-ABCD1 (left) and anti-GFP (right) antibodies after membrane stripping, and the same native molecular mass marker lane is indicated in both panels. The
molecular assembly of both proteins remained unchanged whatever the pretreatment done. C, histograms representing the densitometric analysis of
immunoblots of -DDM-solubilized ABCD1 and ABCD2-EGFP from the induced clone 28.38 peroxisome-enriched fraction preincubated in the presence of 4
mMATP (); 0.2 () or 0.8mM-cyclodextrine (); 4 () or 16MC26:0 (); or cytosol () or 4-folddilution (), separately or in combination as indicated.
D, native-PAGE profiles of solubilized ABCD1 and ABCD2-EGFP, as described in C. The same PVDF membrane was used for immunoblotting with anti-ABCD1
(left) and anti-GFP (right) antibodies, and the same native molecular mass marker lane is indicated at the left of both panels. The molecular assembly of both
proteins (i.e. the 350-kDa ABCD1 complex and the 480-kDa ABCD2-EGFP complex) remained unchanged whatever the pretreatment done.
Table 1
List of proteins identified in co-immunoprecipitated ABCD2-EGFP complex by LC-MS/MS
Protein
accession
Protein
symbol Protein name
No. of
peptidesa
Protein
probability
Sequence
coverage Changeb
% -fold
Q9QY44 ABCD2 ATP-binding cassette sub-family D member 2 28 (2) 1 51.7 12.42
P97612 FAAH1 Fatty-acid amide hydrolase 1 4 1 13.1 5.02
P11507 AT2A2 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 27 (7) 1 34.6 4.71
P07340 AT1B1 Sodium/potassium-transporting ATPase subunit beta-1 3 1 25 2.48
P55159 PON1 Serum paraoxonase/arylesterase 1 9 1 40.8 2.32
D3ZHR2 ABCD1 ATP-binding cassette sub-family D member 1 7 (2) 1 17 	 2
P16970 ABCD3 ATP-binding cassette sub-family D member 3 4 1 11.1 	 2
Q7TS56 CBR4 Carbonyl reductase family member 4 3 1 17.4 	 2
P11505 AT2B1 Plasma membrane calcium-transporting ATPase 1 6 (2) 1 6.6 	 2
P16086 SPTN1 Spectrin  chain, non-erythrocytic 1 8 1 3.9 	 2
Q63151 ACSL3 Long-chain acyl-CoA synthetase 3 3 0.9997 6.9 	 2
O88813 ACSL5 Long-chain acyl-CoA synthetase 5 2 0.9994 3.4 	 2
P14408 FUMH Fumarate hydratase, mitochondrial 1 0.8013 3.9 	 2
P25235 RPN2 glycosyltransferase subunit 2 1 0.7224 3.8 	 2
a Numbers in parentheses refer to the numbers of shared peptides between homologous proteins among the total number of peptides indicated.
b Statistical significance was obtained for proteins identified with a -fold change 2.
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erodimers might not be favored or even might not exist in vivo.
Hence, the absence of or minor heterointeraction within a
dimer and the existence of heterotetramers suggest that het-
erotetramers would be mainly composed of two different
homodimers.
In theABC field, the structure-function relationship remains
difficult to establish for such intractable proteins, and only a few
reports have been published. Yang et al. (28) succeeded in dem-
onstrating that the functional unit of the full-length transporter
ABCC1 involved in multidrug resistance is a dimer, thanks to
anABCC1mutant that has a dominant-negative functionwhen
co-expressed with wild-type ABCC1. Interestingly, for the cho-
lesterol full-length transporter ABCA1, a dimer-monomer
interconversion occurred during HDL generation revealed by
single-molecule imaging (26). The oligomerization (mono-
mers, dimers, and even tetramers) of the surfactant lipid trans-
porter ABCA3, a full-length ABC, was suggested to be crucial
for its function (27). Concerning ABCD1, acyl-CoA binding
induced conformational changes, as assessed by a protease-
based approach (40). However, these conformational changes
probably do not affect the overall molecular assembly of the
transporter because the ABCD1 tetrameric assembly remained
unchanged during the catalytic cycle. Thus, contrary toABCA1
and ABCA3, for which both monomeric and oligomeric forms
co-exist during the catalytic cycle, ABCD1 and ABCD2 are
likely to form obligate tetramers during this cycle.
In ABC transporters, a tight cross-talk between substrate
binding and ATP binding has been extensively described and is
associated with the modification of the inward/outward-facing
structures. Of note, whatever the different biochemical
approaches used in our study, difficulties in solubilizing ABC
transporters from the peroxisomal membrane were overcome
by preincubation of peroxisomes with ATP before the solubili-
zation step. We hypothesized that the difference in solubility
could be due to the supposed different conformations adopted
by the transporters during the catalytic cycle. Indeed, ABC
transporters were described as adopting an inward-facing
conformation, with very large separation of the NBDs in the
absence of ATP, and an outward-facing conformation with a
smaller separation of the NBDs when bound to nucleotides
(41). Thus, a transporter in an outward-facing conformation,
which is themost compact structure, should be easier to extract
from the peroxisomal membrane by the detergent micelle. It
could also be postulated that the observed resistance to-DDM
solubilization is related to the association of peroxisomal ABC
transporters with detergent-resistant microdomains. In the
presence of ATP, both transporters would be distributed out-
side the detergent-resistant microdomains and hence would be
easily solubilizable. ABCD1 and ABCD3were indeed described
as being associated with different detergent-resistant microdo-
mains in peroxisomes of hepatocytes (42). Further experiments
should be done to shed light on this increased solubility medi-
ated by ATP, which certainly has a biological relevance.
In any even, the fact that heterotetramers of ABCD1 and
ABCD2 would be composed of two different homodimers is of
particular interest. In a previous study, we have demonstrated a
transdominant-negative effect of mutated ABCD2 on ABCD1
function (8). In light of the current results, it would mean that
the functional unit is at minimum a tetramer. If ABCD1
tetramerization is indeed crucial for its function, disruption of
oligomerization due to mutations could represent a novel
pathomechanism in X-ALD. It is thus important to determine
whether ABCD1 mutations that are found in X-ALD patients
have any impact on its tetramerization. Among the300 non-
recurrent missense ABCD1 gene mutations distributed all
along the protein sequence, those located in the last 87 C-ter-
minal amino acids could be of interest because this region has
been reported to be involved in ABCD1 interaction with itself
and with ABCD2 and ABCD3 (19, 21).
The native-PAGE profiles obtained suggest that besides
tetrameric forms, higher molecular assemblies of ABCD1 and
ABCD2 are present, up to 720 kDa. Coincidently, similar
native-PAGE experiments from Arabidopsis thaliana cultured
cells showed the presence of the unique peroxisomal ABC
transporter (i.e. COMATOSE, a full-length transporter ortho-
log to ABCD1) in a complex of700 kDa (43). Several studies
have reported physical interaction between the peroxisomal
ABCD transporters and other proteins, such as the very long-
chain acyl-CoA synthetases 1 and 4 (ACSVL1 and -4), the ATP
citrate synthase, the fatty-acid synthase variant protein (FASN),
the phytanoyl-CoA 2-hydroxylase, and PEX19p (39, 44–46).
Large complexes containing ABC transporters and accessory
proteins are frequent in the ABC family. Moreover, such inter-
actions are in agreement with the hydrophobic nature of the
substrates, which probably require a “continual chaperoning”
from the cytosol to the peroxisomal matrix. Among the
interacting partners listed above, only PEX19p has been
reported to interact with the ABCD2 transporter (46). The
co-IP/MS strategy developed in the present study has been
adapted to membrane proteins and successfully identified
potential binding partners of ABCD2, including soluble and
membrane proteins. These partners are different from those
previously identified for ABCD1, ABCD2, and ABCD3 (39,
44–46). Interestingly, they are distributed in the peroxisome
(ABCD1 and ABCD3) but also in the cytoplasm (spectrin 
chain, SPTN1), in lipid droplets (long-chain acyl-CoA syn-
thetase 3 (ACSL3)), and in other organelles, such as endo-
plasmic reticulum (FAAH1 and long-chain acyl-CoA syn-
thetase 3 (ACSL3)) and mitochondria (carbonyl reductase
family member 4 (CBR4) and ACSL5). These data corroborate
the existence of peroxisome interconnection with organelles,
lipid droplets, and the cytoskeleton (47). The first molecular
mechanism for establishing peroxisome-endoplasmic reticu-
lum associations has been discovered recently (48, 49). More-
over, it has been evidenced recently that ABCD2 is localized to
a subclass of peroxisome that may associate physically with
mitochondria and the endoplasmic reticulum (50). Neverthe-
less, themechanisms leading to such physical contacts between
these different cell compartments and the physiological rele-
vance of these interactions are largely unknown.
The co-IP/MS experiment succeeded in identifying ABCD1
and ABCD3 proteins as ABCD2-binding partners, despite the
presence of degenerate peptides (two shared peptides between
ABCD1 and ABCD2), which brings uncertainty and ambiguity
in determining the identities of sample proteins (51). The -fold
change between samples expressing or not ABCD2-EGFP was
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used as a guide for specific interaction. Although ABCD1 and
ABCD3 were identified with a -fold change less than the arbi-
trary threshold value of 2, ABCD1 andABCD3 are true ABCD2
partners, judging from the present co-IP assays and from pre-
vious reports (8, 19, 20, 24).
The protein identified with the highest -fold change is
FAAH1 localized at the endoplasmic reticulum and responsible
for the degradation of fatty-acid amides to the corresponding
fatty acids, with a preference of PUFA over MUFA and satu-
rated fatty acids, at least for the long-chain fatty acids tested (52,
53). As a reminder, ABCD2, but not ABCD1 or ABCD3, would
be involved in the transport of PUFA, such as docosahexaenoic
acid (DHA) (C22:6 n-3) (5, 8). Interestingly, the ethanolamine
amide of DHA (N-docosahexaenoyl ethanolamine) is degraded
to DHA by the FAAH1 (54), and DHA is known to be -oxi-
dized into the peroxisome (55). Hence, it is tempting to specu-
late that FAAH1 interaction with ABCD2 permits to supply the
PUFA substrate toABCD2 for further degradation into the per-
oxisome.Other potential binding partners of ABCD2 identified
are involved in lipid metabolism, such as CBR4 and the long-
chain acyl-CoA synthetase 3 and 5 (ACSL3 and ACSL5). Inter-
estingly, ACSL3 has a substrate preference for PUFA (56).
AT2A2 was also identified with a high -fold change, suggest-
ing that this protein is also a true interactor of ABCD2. In addi-
tion, its homolog (AT2A1) has been identified by proteomic
analysis in a subclass of peroxisome expressing ABCD2 (50). By
transferring Ca2 from the cytosol to the endoplasmic reticu-
lum, this enzyme is involved in calcium signaling. Interestingly,
disturbed calcium signaling was recently proposed to be
involved in the pathogenesis of X-ALD (57). Altogether, the
link between ABCD2 and calcium signaling would require fur-
ther investigation, especially because the calcium-transporting
ATPase 1 (AT2B1),which is expressed at the plasmamembrane
and transports calcium out of the cell, was also identified as a
potential interactor of ABCD2 (Table 1).
In conclusion, the characterization of the quaternary struc-
ture of ABCD1 and its homolog ABCD2 demonstrated for the
first time that both proteins exist as tetramers, mainly homote-
tramers, in the peroxisomal membrane. However, the func-
tional significance of this tetramerization remains unknown. A
question that is still pending is whether or not oligomerization
participates in substrate specificity. Molecular complexes of
higher molecular weight were also observed and remain to be
characterized in detail. In addition, we identified potential
binding partners of ABCD2, involved in PUFAmetabolism and
calcium signaling, whose interaction with ABCD2 remains to
be confirmed and whose physiological relevance remains to be
elucidated.
Experimental procedures
Cell culture
H4IIEC3 rat hepatoma cells stably expressing ABCD2-EGFP
(clone 28.38) (8, 31) were cultured as described previously. COS-
7 cells (ECACCcatalog no. 87021302)were grown inDMEMsup-
plemented with 10% FBS. Murine microglial cells (BV-2) from
Banca-Biologica e Cell Factory (catalog no. ATL03001) were cul-
tured inDMEMsupplementedwith10%heat-inactivatedFBSand
1% penicillin/streptomycin (Dutscher). Cultures weremaintained
at 37 °C in a humidified atmosphere containing 5% CO2.
Plasmid constructs
For COS-7 cell transfection, the pEGFP-N3 plasmids coding
for the chimeric dimers fused to EGFP (ABCD1-ABCD1-EGFP
and ABCD2-ABCD2-EGFP) were obtained previously (24).
The pcDNA3.1() plasmids coding for ABCD1-ABCD1 and
ABCD2-ABCD2 were obtained by a similar strategy (24) and
generated chimeric proteins containing two moieties linked by
3 alanine residues.
Transfection
COS-7 cells (500,000 cells at 70–80% confluence) were tran-
siently transfected with plasmids (4 g for a single transfection
or 2 g of each plasmid for double transfection) coding for the
chimeric dimers (pEGFP-N3 or pcDNA3.1() plasmids) using
the ExGen 500 in vitro transfection reagent (Euromedex),
according to the manufacturer’s instructions. After transfec-
tion, cells were cultured inDMEMsupplementedwith 10% FBS
for 48 h and then lysed for further experiments.
Peroxisome-enriched fraction isolation by subcellular
fractionation
Cells (from 10 140-mm-diameter Petri dishes at 80–90%
confluence) were homogenized in 100 ml of homogenization
buffer (HB) (250mM sucrose, 1mMEDTA, 0.1% ethanol, 50mM
Tris-HCl, pH 7.5) by six strokes with a Dounce homogenizer
(pestle B) followed by centrifugation at 1,000
 g for 5min. The
pellet was suspended in HB, and homogenization was repeated
twice. Supernatants were pooled and then centrifuged first at
7,500
 g for 4 min, 8 s and second at 55,000
 g for 4 min, 48 s
to pellet peroxisomes, lysosomes, and lightmitochondria. After
pellet resuspension in 5 ml of HB and protein concentration
measurement using the bicinchoninic acid assay (BCA; Sigma-
Aldrich), the peroxisome-enriched fraction (L fraction) (58)
was subjected to ABCD protein solubilization assays.
Cytosolic fractions were prepared from 8 140-mm-diameter
Petri dishes at 80–90% confluence of H4IIEC3 rat hepatoma
cells stably expressing ABCD2-EGFP (clone 28.38  2 g/ml
doxycycline overnight). Cells were homogenized (Dounce, pes-
tle B) in 2 ml of HB, and the homogenate was centrifuged at
199,000
 g for 45 min. The resulting supernatant corresponds
to the cytosolic fraction.
ABCD protein solubilization assays from the peroxisome-
enriched fraction
The peroxisome-enriched pellet was suspended (20 g/150
l) in the treatment buffer (0.25 M sucrose, 10 mM MgCl2, 50
mM Tris-HCl, pH 8.0) containing separately or in combination
4 mM ATP (Sigma-Aldrich), 4 mM AMP-PNP (Sigma-Aldrich),
0.8mM-cyclodextrine (Sigma-Aldrich), 4 or 16MC26:0, and
a 1:5 dilution () or 2:5 dilution () of the cytosol. The mix-
ture was incubated at 37 °C for 40 min, and after centrifugation
at 20,000
 g for 20 min, the pellet was suspended in the solu-
bilization buffer (50 mM Tris-HCl, 150 mM NaCl, 0.4% deter-
gent, pH 8.0) for 30 min at 4 °C (15 l/pellet). After centrifuga-
tion (20,000
 g for 20min at 4 °C), the supernatant (containing
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solubilized proteins) and/or the pellet (containing insoluble
proteins) were either loaded on SDS-PAGE or on native PAGE
for further analysis.
Velocity sucrose gradient centrifugation
COS-7 cells transfected with pABCD2-ABCD2-EGFP-N3
plasmid (48 h post-transfection) or H4IIEC3 rat hepatoma cells
stably expressing ABCD2-EGFP (clone 28.38 2 g/ml doxy-
cycline overnight) and at 80–90% confluence were washed
twicewith phosphate-buffered saline (PBS). The cellswere then
solubilized at 4 °C for 30 min in 150 mM NaCl and 50 mM Tris-
HCl, pH 7.4, in the presence of 1% SDS, 1% of the anionic
calix[4]arene-based detergent C4C8 (30), 1% Triton X-
100 (Euromedex), 1% -DDM (Anatrace), or 1% -DDM
(Anatrace) and supplemented with a protease inhibitor mix-
ture (Roche Diagnostics) plus 1mM phenylmethylsulfonyl fluo-
ride (PMSF). After centrifugation at 20,000 
 g at 4 °C for 20
min, the cleared post-nuclear supernatant was collected, and
protein concentration was measured by BCA. Post-nuclear
supernatants (2.5 mg) adjusted to 400l were layered on top of
a discontinuous 5–30% (w/v) sucrose gradient prepared by suc-
cessive layers of 2.5 ml of 30% (w/v), 2 ml of 20%, 2 ml of 15%, 2
ml of 10%, and 2 ml of 5% sucrose in 50 mM Tris-HCl (pH 7.4),
150mMNaCl, and the appropriate detergent. The overlaid gra-
dients were subjected to ultracentrifugation in a SW41 rotor at
260,000
 g for 12 h at 4 °C except for SDS gradients (24 °C). At
equilibrium, twenty-two 500-l fractions were collected and
numbered from top to bottom. For sucrose gradients loaded
with lysate of ABCD2-ABCD2-EGFP-transfected COS-7 cells,
protein samples from each fraction collected were concen-
trated 5 times by acetone precipitation. Each fraction (50 l,
concentrated or not)was analyzed forABCD1andABCD2con-
tents by immunoblotting. Sucrose gradient linearity was con-
firmed by refractometry (Abbe-2WAJ) on blank gradients.
Because the estimation of the approximatemolecular weight
of membrane protein complexes by comparison with sedimen-
tation of soluble protein standards is complicated by the con-
tribution of unknown amounts of bound detergent in the
micelle and by the fact that micelles may affect buoyancy, we
included a membrane protein marker, the chimeric dimer
ABCD2-ABCD2-EGFP. Native soluble proteinmarkers (thyro-
globulin (669 kDa), catalase (232 kDa), -amylase (200 kDa),
conalbumin (75 kDa), ovalbumin (44 kDa)) and a denatured
membrane protein marker ABCD2-ABCD2-EGFP (194 kDa)
were run in parallel gradients. Peak migration of soluble mark-
ers and of the membrane marker was determined by absor-
bance at 280 nm or by immunoblotting analysis, respectively,
for all fractions.
Co-IP assays
Mouse monoclonal anti-GFP antibody covalently immobi-
lized on agarose beads (MBL) and homemade rabbit polyclonal
anti-ABCD1 antibody (serum 029) cross-linked to agarose
beads via dimethyl pimelimidate (24) were used for co-IP
assays. COS-7 cells transiently transfected with plasmids (cod-
ing for ABCD1-ABCD1, ABCD1-ABCD1-EGFP, ABCD2-
ABCD2, ABCD2-ABCD2-EGFP) and H4IIEC3 cells stably
expressing ABCD2-EGFP (clone 28.38  2 g/ml of doxycy-
cline overnight) or not were homogenized in the solubilization
buffer: 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% detergent
(C4C8 (30), Triton X-100, or -DDM), 1 mM PMSF, and pro-
tease inhibitor mixtures (Roche Diagnostics). Immunoprecipi-
tation assays (from 200 to 1,600 g of precleared cell lysate)
were carried out as described previously (24). Bound proteins,
including IP and co-IP proteins, were analyzed by SDS-PAGE,
followed by immunoblotting with anti-ABCD1, anti-ABCD2,
and anti-GFP antibodies.
For co-IP assays coupled to mass spectrometry, the peroxi-
some-enriched fractions were prepared as described from the
clone 28.38 expressing or not expressing ABCD2-EGFP (with
or without 2 g/ml doxycycline overnight). The -DDM-solu-
ble fractions of the peroxisome-enriched fraction (300 g)
were subjected to anti-GFP (covalently immobilized on aga-
rose beads (MBL)) co-IP assays. Eluted proteins were further
identified by LC-MS/MS.
Native-PAGE fractionation and analysis
Solubilized proteins (with 0.4% -DDM containing solubili-
zation buffer) from peroxisome-enriched fractions (20 g/as-
say) preincubated with fatty acid and/or cytosolic fraction
and/or ATP or derivatives were loaded on a Deriphat native
PAGE as described previously (36). Samples were fractionated
on 4–16% native-PAGE BisTris gel (Life Technologies, Inc.),
and 0.1% Deriphat was included in the upper reservoir. After
electrophoresis at 4 °C at 50 V for 12 h, proteins were trans-
ferred onto a PVDF membrane at 4 °C in 25 mM Tris, 192 mM
glycine, and 20% (v/v) methanol. PVDF membranes were fur-
ther probed with antibodies to detect the presence of ABCD1
and ABCD2 proteins. The migration of native marker un-
stained protein standards (Invitrogen) was analyzed by Coo-
massie Brilliant Blue G staining (Sigma-Aldrich) of an excised
marker lane of the gel and by Ponceau S staining of the PVDF
membrane.
Western blotting
Proteins from total cell lysate (40–50 g), proteins solubi-
lized or not from peroxisome-enriched fraction (20 g/assay),
velocity sucrose gradient fractions concentrated or not (50 l),
and immunoprecipitated proteinswere separated on 7.5%SDS-
PAGE or on 4–16% native Deriphat-PAGE and transferred
onto a PVDFmembrane. First incubated in 5% skimmedmilk in
PBS, 0.1% Tween 20 (PBS/T) for 1 h at room temperature, the
membrane was then probed with mouse anti--actin (dilution
1:10,000; Sigma-Aldrich), mouse anti-GFP (dilution 1:250;
Roche Diagnostics), rabbit polyclonal anti-ABCD1 (1:5,000;
homemade serum 029) (24), or rabbit polyclonal anti-ABCD2
(generous gift from Prof. G. Graf, University of Kentucky) (9)
antibodies. The anti-ABCD1 and anti-ABCD2 antibodies do
not cross-react with ABCD2 and ABCD1, respectively (data
not shown). Following the incubation with the appropriate
horseradish peroxidase (HRP)-conjugated secondary anti-
body (1:5,000; Santa Cruz Biotechnology, Inc.), immunoreac-
tivity was revealed by ECL (Santa Cruz Biotechnology). Image
processing and analysis were obtained using a Bio-Rad-Chemi-
doc XRS system and the Image Lab version 4.0 software for
quantitative analysis. The double band detected with the anti-
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GFP antibodies on immunoblots obtained from SDS-PAGE
corresponds to two different denatured states of the ABCD2-
EGFP protein: a fully denatured protein (upper band) and a
partially denatured protein (lower band). These two bandswere
obtained because samples were not boiled to avoid membrane
protein aggregation. Both bands were systematically consid-
ered when immunoblots were subjected to densitometric
analysis.
Protein identification by LC-MS/MS
Eluted proteins from co-IP assays were separated (short gel
run, 1 cm) on 1D PAGE (Invitrogen). This 1-cm area was cut in
spots and washed with 0.1 M NH4HCO3 and next with 100%
acetonitrile (ACN) for 10 min. Reduction/alkylation was
achieved by incubating the excised spots successively in 10 mM
tris(2-carboxyethyl) phosphine, 0.1 M NH4HCO3 for 30 min at
37 °C and in 55mM iodoacetamide, 0.1 MNH4HCO3 for 20min.
Peptide fragments were obtained after digestionwith a solution
of 40 mM NH4HCO3, 10% ACN containing 5 ng/l trypsin
(Promega) for 3 h at 37 °C. The resulting peptideswere acidified
with 0.1% formic acid. Extraction from the polyacrylamide gel
pieces was performed by two successive incubations for a few
min in ACN with sonication.
Peptides were further concentrated by evaporation and
separated with the Ultimate 3000 RSLC nano system (Thermo-
Scientific) fitted with a C18 trapping column (5-m average
particle diameter; 300-m inner diameter 
 5-mm length;
ThermoScientific) and a C18 analytical column (2-m average
particle diameter, 75-m inner diameter 
 150-mm length;
ThermoScientific). A 120-min gradient was performed, and
peptides were analyzed by nano-LC-MS/MS using an LTQ-
Orbitrap Elite mass spectrometer equipped with the Advion
TriVersa NanoMate nanospray source. Full-scan spectra from
a mass/charge ratio of 400 to one of 1,700 at a resolution of
120,000 full width at half-maximum were acquired in the
Orbitrap mass spectrometer. From each full-scan spectrum,
the 20 ionswith the highest intensitywere selected for fragmen-
tation in the ion trap, and a 30-s exclusion time was defined.
Each sample was analyzed in triplicate.
The acquired data were searched against the International
Protein Index/UniProt using Mascot and X!Tandem. Based on
tandem mass spectrometry data, peptide and protein identifi-
cations were validated through Peptide and ProteinProphet
software (59). At the end of the above steps, each injection was
described by a list of validated proteins and peptides. Peptides
that were not identified in at least 2 of the 3 technical replicates
injected per sample were excluded. Retention times were then
aligned, and peptide intensity was extracted using the MASIC
software (60). Using this quantification, a new filter based on
the coefficients of variation of each peptide in each sample is
applied to discard too poorly reproducible peptides. A linear
mixedmodel is then used to select differential proteins between
the positive (dox) and negative (dox) conditions (61). The
false-discovery rate correction was applied to take into account
the high dimension (far more tested variables than samples).
Proteins identified with a -fold change higher than 2, with a
false-discovery rate at 5%, were kept. Proteins detected
exclusively in the positive samples but absent in the negative
samples are also listed even if their presence is not statisti-
cally relevant.
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